We estimate that the CEO of BECTON DICKINSON & CO ($BDX), Thomas E. Polen, received a compensation of $17,129,140 in 2025. This is a decrease of -1.08% from an estimated $17,314,606 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on December 18, 2025. Note that parsing errors may occur.
You can track $BDX on Quiver Quantitative's $BDX stock dashboard.
$BDX Stock Insider Trading Activity
$BDX Stock insiders have traded $BDX stock on the open market 11 times in the past 6 months. Of those trades, 1 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- GREGORY HAYES purchased 5,250 shares for an estimated $1,005,742
- CLAIRE FRASER has made 0 purchases and 2 sales selling 1,780 shares for an estimated $337,892.
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 3 sales selling 1,814 shares for an estimated $336,947.
- MICHAEL FELD (EVP, CRO & Pres. Life Sciences) has made 0 purchases and 4 sales selling 247 shares for an estimated $46,889.
- BERTRAM L SCOTT sold 217 shares for an estimated $38,317
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BDX Stock Government Contracts
We have seen $98,503,499 of award payments to $BDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INFUSION PUMPS AND SERVICES: $5,519,658
- INFUSION PUMPS MULTIPLE-AWARD IDIQ VISN 10 ORDER: $5,252,124
- INFUSION PUMPS: $5,057,297
- 8511358199!PHARMACY AUTOMATION MAINTENAN: $4,072,311
- FLEET REPLACEMENT INFUSION PUMPS: $2,996,961
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$BDX Stock Congressional Stock Trading
Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BDX Stock Hedge Fund Activity
We have seen 721 institutional investors add shares of $BDX Stock stock to their portfolio, and 901 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 5,174,944 shares (+9056.3%) to their portfolio in Q3 2025, for an estimated $968,594,268
- PRICE T ROWE ASSOCIATES INC /MD/ removed 4,261,237 shares (-48.0%) from their portfolio in Q3 2025, for an estimated $797,575,729
- FRANKLIN RESOURCES INC added 4,051,718 shares (+150.9%) to their portfolio in Q3 2025, for an estimated $758,360,058
- GQG PARTNERS LLC removed 3,011,583 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $518,745,171
- MANUFACTURERS LIFE INSURANCE COMPANY, THE added 2,258,179 shares (+706.6%) to their portfolio in Q3 2025, for an estimated $422,663,363
- ONTARIO TEACHERS PENSION PLAN BOARD removed 1,448,293 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $249,468,469
- STARBOARD VALUE LP removed 1,411,492 shares (-53.9%) from their portfolio in Q3 2025, for an estimated $264,188,957
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BDX Stock Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 4 analysts offer price targets for $BDX in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Shagun Singh from RBC Capital set a target price of $210.0 on 12/17/2025
- Patrick Wood from Morgan Stanley set a target price of $210.0 on 12/02/2025
- Jason Bednar from Piper Sandler set a target price of $190.0 on 11/07/2025
- Lawrence Biegelsen from Wells Fargo set a target price of $184.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
